NCR3 and neoplasm: Similar to the NKG2D ligands MICA and MICB, the NKp30 ligand B7-H6 could be cleaved from the surface of tumor cells and released as soluble B7-H6, thus preventing the NKp30-mediated recognition of tumor cells [52,53] (Figure 1).